3-year Treatment of Tenofovir Alafenamide vs. Tenofovir Disoproxil Fumarate for Chronic HBV Infection in China

BACKGROUND AND AIMS: Tenofovir alafenamide (TAF) has similar efficacy to tenofovir disoproxil fumarate (TDF) but with improved renal and bone safety in chronic hepatitis B patients studied outside of China. We report 3-year results from two phase 3 studies with TAF in China (Clinicaltrials.gov: NCT0...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Jinlin, Ning, Qin, Duan, Zhongping, Chen, You, Xie, Qing, Wang, Fu-Sheng, Zhang, Lunli, Wu, Shanming, Tang, Hong, Li, Jun, Lin, Feng, Yang, Yongfeng, Gong, Guozhong, Flaherty, John F., Gaggar, Anuj, Mo, Shuyuan, Cheng, Cong, Camus, Gregory, Chen, Chengwei, Huang, Yan, Jia, Jidong, Zhang, Mingxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237145/
https://www.ncbi.nlm.nih.gov/pubmed/34221918
http://dx.doi.org/10.14218/JCTH.2020.00145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8237145/
https://www.ncbi.nlm.nih.gov/pubmed/34221918
http://dx.doi.org/10.14218/JCTH.2020.00145

Ejemplares similares